Zymeworks (ZYME) Completes Theravance Biopharma Acquisition, Eyes Growth in COPD Market
· gurufocus.com
On September 28, 2026, Zymeworks Inc (NASDAQ: ZYME) finalized its acquisition of Theravance Biopharma, a strategic move expected to boost revenue and cash flow
On September 28, 2026, Zymeworks Inc (NASDAQ: ZYME) finalized its acquisition of Theravance Biopharma, a strategic move expected to boost revenue and cash flow ...